Gao S et al. showed in vivo that circ-IGF1R promotes tumor growth and glycolytic metabolism by activating the Wnt/β-catenin pathway through the regulation of the miR-362-5p/HMGB3 axis. The gene discussed is HMGB3; the disease is neoplasm.